Nanopore logoCompany profile

Nanopore

Nanopore has raised $1.26B in funding, including key rounds such as $64.2M Post-IPO (2024), $84.5M Post-IPO (2023), and a major $270M Series H (2021) backed by investors like M&G, Temasek, Wellington, and Nikon. Founded in 2005, the company pioneered real-time nanopore sequencing technology and has since become a leader in molecular analysis and genomics. With significant backing from global biotech and institutional investors, Nanopore continues to scale its technology for clinical diagnostics, research, and industrial applications worldwide.

Back to profiles

Quick facts

Total funding
$1.26B
Founded
2005

Notable investors

  • Temasek
  • Wellington
  • Nikon

Reach buyers like Nanopore.

The 14-day trial ships every feature, no card required.